Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Interventions for the prevention of risk factors and incidence of type 2 diabetes in the work environment: a systematic review.

Inolopú J, Hilario-Huapaya N, Tantaleán-Del-Águila MA, Hurtado-Roca Y, Ugarte-Gil C.

Rev Saude Publica. 2019 Dec 2;53:101. doi: 10.11606/s1518-8787.2019053001084. eCollection 2019. English, Spanish.

2.

Correction to: International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol.

Lebov JF, Arias JF, Balmaseda A, Britt W, Cordero JF, Galvão LA, Garces AL, Hambidge KM, Harris E, Ko A, Krebs N, Marques ETA, Martinez AM, McClure E, Miranda-Filho DB, Moreira MEL, Mussi-Pinhata MM, Ochoa TJ, Osorio JE, Scalabrin DMF, Schultz-Cherry S, Seage GR 3rd, Stolka K, Ugarte-Gil CA, Vega CMV, Welton M, Ximenes R, Zorrilla C.

BMC Pregnancy Childbirth. 2019 Nov 19;19(1):423. doi: 10.1186/s12884-019-2589-8.

3.

Is there an association between cutaneous leishmaniasis and skin cancer? A systematic review.

Carrillo-Larco RM, Acevedo-Rodriguez JG, Altez-Fernandez C, Ortiz-Acha K, Ugarte-Gil C.

Wellcome Open Res. 2019 Jul 23;4:110. doi: 10.12688/wellcomeopenres.15367.1. eCollection 2019.

4.

The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis.

Huangfu P, Ugarte-Gil C, Golub J, Pearson F, Critchley J.

Int J Tuberc Lung Dis. 2019 Jul 1;23(7):783-796. doi: 10.5588/ijtld.18.0433.

PMID:
31439109
5.

International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol.

Lebov JF, Arias JF, Balmaseda A, Britt W, Cordero JF, Galvão LA, Garces AL, Hambidge KM, Harris E, Ko A, Krebs N, Marques ETA, Martinez AM, McClure E, Miranda-Filho DB, Moreira MEL, Mussi-Pinhata MM, Ochoa TJ, Osorio JE, Scalabrin DMF, Schultz-Cherry S, Seage GR 3rd, Stolka K, Ugarte-Gil CA, Vega CMV, Welton M, Ximenes R, Zorrilla C.

BMC Pregnancy Childbirth. 2019 Aug 7;19(1):282. doi: 10.1186/s12884-019-2430-4. Erratum in: BMC Pregnancy Childbirth. 2019 Nov 19;19(1):423.

6.

Reply to Yates and Barr.

Ugarte-Gil C, Pearson F, Moore D, Critchley J, van Crevel R.

Clin Infect Dis. 2019 May 24. pii: ciz434. doi: 10.1093/cid/ciz434. [Epub ahead of print] No abstract available.

PMID:
31247066
7.

Vulnerable populations and the right to health: lessons from the Peruvian Amazon around tuberculosis control.

Gianella C, Pesantes MA, Ugarte-Gil C, Moore DAJ, Lema C.

Int J Equity Health. 2019 Jun 3;18(1):28. doi: 10.1186/s12939-019-0928-z.

8.

Leptospirosis as a risk factor for chronic kidney disease: A systematic review of observational studies.

Carrillo-Larco RM, Altez-Fernandez C, Acevedo-Rodriguez JG, Ortiz-Acha K, Ugarte-Gil C.

PLoS Negl Trop Dis. 2019 May 23;13(5):e0007458. doi: 10.1371/journal.pntd.0007458. eCollection 2019 May.

9.

Diabetes mellitus among pulmonary tuberculosis patients from four TB-endemic countries: the TANDEM study.

Ugarte-Gil C, Alisjahbana B, Ronacher K, Riza AL, Koesoemadinata RC, Malherbe ST, Cioboata R, Llontop JC, Kleynhans L, Lopez S, Santoso P, Marius C, Villaizan K, Ruslami R, Walzl G, Panduru NM, Dockrell HM, Hill PC, Mc Allister S, Pearson F, Moore DAJ, Critchley JA, van Crevel R; TANDEM Consortium.

Clin Infect Dis. 2019 Apr 8. pii: ciz284. doi: 10.1093/cid/ciz284. [Epub ahead of print]

PMID:
30958536
10.

Point of care HbA1c level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries.

Huangfu P, Laurence YV, Alisjahbana B, Ugarte-Gil C, Riza AL, Walzl G, Ruslami R, Moore DAJ, Ioana M, McAllister S, Ronacher K, Koesoemadinata RC, Grint D, Kerry S, Coronel J, Malherbe ST, Griffiths U, Dockrell HM, Hill PC, van Crevel R, Pearson F, Critchley JA.

Int J Tuberc Lung Dis. 2019 Mar 1;23(3):283-292. doi: 10.5588/ijtld.18.0359.

PMID:
30871659
11.

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.

Petersen E, Rao M, Ippolito G, Gualano G, Chakaya J, Ntoumi F, Moore D, Allen R, Gaskell K, Öhd JN, Hergens MP, Krishnamoorthy S, Ugarte-Gil C, Kirwan DE, Honeyborne I, McHugh TD, Köser CU, Kranzer K, Tiberi S, Migliori GB, Mao Q, Yang Y, Oliveira SP, Cardoso RF, Detjen A, Marais B, de Gijsel D, von Reyn CF, Goscé L, Abubakar I, Maeurer M, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S1-S5. doi: 10.1016/j.ijid.2019.02.024. Epub 2019 Feb 23. No abstract available.

12.

Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis.

Ugarte-Gil C, Carrillo-Larco RM, Kirwan DE.

Int J Infect Dis. 2019 Mar;80S:S29-S31. doi: 10.1016/j.ijid.2019.02.018. Epub 2019 Feb 22. Review.

13.

Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C.

Tuberculosis (Edinb). 2018 Dec;113:153-162. doi: 10.1016/j.tube.2018.09.009. Epub 2018 Oct 1.

14.

Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa.

Grint D, Alisjhabana B, Ugarte-Gil C, Riza AL, Walzl G, Pearson F, Ruslami R, Moore DAJ, Ioana M, McAllister S, Ronacher K, Koeseomadinata RC, Kerry-Barnard SR, Coronel J, Malherbe ST, Dockrell HM, Hill PC, Van Crevel R, Critchley JA; TANDEM consortium.

Bull World Health Organ. 2018 Nov 1;96(11):738-749. doi: 10.2471/BLT.17.206227. Epub 2018 Aug 27.

15.

Disease characteristics and treatment of patients with diabetes mellitus attending government health services in Indonesia, Peru, Romania and South Africa.

Soetedjo NNM, McAllister SM, Ugarte-Gil C, Firanescu AG, Ronacher K, Alisjahbana B, Costache AL, Zubiate C, Malherbe ST, Koesoemadinata RC, Laurence YV, Pearson F, Kerry-Barnard S, Ruslami R, Moore DAJ, Ioana M, Kleynhans L, Permana H, Hill PC, Mota M, Walzl G, Dockrell HM, Critchley JA, van Crevel R; TANDEM Consortium.

Trop Med Int Health. 2018 Oct;23(10):1118-1128. doi: 10.1111/tmi.13137. Epub 2018 Sep 10.

16.

Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.

Huangfu P, Pearson F, Ugarte-Gil C, Critchley J.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1214-1219. doi: 10.5588/ijtld.17.0211.

PMID:
29297440
17.

Histological Examination in Obtaining a Diagnosis in Patients with Lymphadenopathy in Lima, Peru.

Kirwan DE, Ugarte-Gil C, Gilman RH, Hasan Rizvi SM, Cerrillo G, Cok J, Ticona E, Cabrera JL, Matos ED, Evans CA, Moore DAJ, Friedland JS, The Lymph Node Tuberculosis Lntb Working Group.

Am J Trop Med Hyg. 2017 Oct;97(4):1271-1276. doi: 10.4269/ajtmh.16-0961.

18.

Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis.

Echecopar-Sabogal J, D'Angelo-Piaggio L, Chanamé-Baca DM, Ugarte-Gil C.

Int J STD AIDS. 2018 Apr;29(5):443-452. doi: 10.1177/0956462417732226. Epub 2017 Sep 28. Review.

PMID:
28956700
19.

Diagnostic accuracy of nucleic acid amplification tests (NAATs) in urine for genitourinary tuberculosis: a systematic review and meta-analysis.

Altez-Fernandez C, Ortiz V, Mirzazadeh M, Zegarra L, Seas C, Ugarte-Gil C.

BMC Infect Dis. 2017 Jun 5;17(1):390. doi: 10.1186/s12879-017-2476-8.

20.

Acerca de "Mapeo político de la discriminación y homofobia asociadas con la epidemia de VIH en México".

Ochoa-Fernández AC, Sánchez-Siancas JE, Ueda-Muro DA, Ugarte-Gil C.

Salud Publica Mex. 2017 Jan-Feb;59(1):8-10. doi: 10.21149/7756. Spanish. No abstract available.

PMID:
28423104
21.

TB in Vulnerable Populations: The Case of an Indigenous Community in the Peruvian Amazon.

Gianella C, Ugarte-Gil C, Caro G, Aylas R, Castro C, Lema C.

Health Hum Rights. 2016 Jun;18(1):55-68.

22.

Diseases masking and delaying the diagnosis of urogenital tuberculosis.

Altez-Fernandez C, Seas C, Zegarra L, Ugarte-Gil C.

Ther Adv Urol. 2016 Jun;8(3):234. doi: 10.1177/1756287216638592. Epub 2016 Mar 15. No abstract available.

23.

An Outbreak of Bartonella bacilliformis in an Endemic Andean Community.

Sanchez Clemente N, Ugarte-Gil C, Solorzano N, Maguiña C, Moore D.

PLoS One. 2016 Mar 18;11(3):e0150525. doi: 10.1371/journal.pone.0150525. eCollection 2016.

24.

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.

Kirwan DE, Ugarte-Gil C, Gilman RH, Caviedes L, Rizvi H, Ticona E, Chavez G, Cabrera JL, Matos ED, Evans CA, Moore DA, Friedland JS; Lymph Node TB Working Group, Peru.

J Clin Microbiol. 2016 Jan;54(1):185-9. doi: 10.1128/JCM.02227-15. Epub 2015 Oct 28.

25.

Social network analysis identified central outcomes for core outcome sets using systematic reviews of HIV/AIDS.

Saldanha IJ, Li T, Yang C, Ugarte-Gil C, Rutherford GW, Dickersin K.

J Clin Epidemiol. 2016 Feb;70:164-75. doi: 10.1016/j.jclinepi.2015.08.023. Epub 2015 Sep 25.

26.

Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.

Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA.

PLoS One. 2015 Jun 4;10(6):e0128004. doi: 10.1371/journal.pone.0128004. eCollection 2015. Review.

27.

Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis.

Ong CW, Elkington PT, Brilha S, Ugarte-Gil C, Tome-Esteban MT, Tezera LB, Pabisiak PJ, Moores RC, Sathyamoorthy T, Patel V, Gilman RH, Porter JC, Friedland JS.

PLoS Pathog. 2015 May 21;11(5):e1004917. doi: 10.1371/journal.ppat.1004917. eCollection 2015 May.

28.

Authors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic review.

Scherer RW, Ugarte-Gil C, Schmucker C, Meerpohl JJ.

J Clin Epidemiol. 2015 Jul;68(7):803-10. doi: 10.1016/j.jclinepi.2015.01.027. Epub 2015 Feb 13. Review.

29.

Multidrug resistant tuberculosis.

Millard J, Ugarte-Gil C, Moore DA.

BMJ. 2015 Feb 26;350:h882. doi: 10.1136/bmj.h882. Review. No abstract available.

30.

Induced sputum is safe and well-tolerated for TB diagnosis in a resource-poor primary healthcare setting.

Ugarte-Gil C, Elkington PT, Gotuzzo E, Friedland JS, Moore DAJ.

Am J Trop Med Hyg. 2015 Mar;92(3):633-635. doi: 10.4269/ajtmh.14-0583. Epub 2014 Dec 22.

31.

HIV stigma as a barrier to retention in HIV care at a general hospital in Lima, Peru: a case-control study.

Valenzuela C, Ugarte-Gil C, Paz J, Echevarria J, Gotuzzo E, Vermund SH, Kipp AM.

AIDS Behav. 2015 Feb;19(2):235-45. doi: 10.1007/s10461-014-0908-7.

32.

Clinical management of concurrent diabetes and tuberculosis and the implications for patient services.

Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM, Hill PC, Ruslami R, Moore D, Aarnoutse R, Critchley JA, van Crevel R.

Lancet Diabetes Endocrinol. 2014 Sep;2(9):740-53. doi: 10.1016/S2213-8587(14)70110-X. Review.

33.

[Tuberculosis and diabetes co-morbidity: an unresolved problem].

Ugarte-Gil C, Moore DA.

Rev Peru Med Exp Salud Publica. 2014;31(1):137-42. Review. Spanish.

34.

Knowledge about HIV prevention and transmission among recently diagnosed tuberculosis patients: a cross sectional study.

Ugarte-Gil C, Ponce M, Zamudio C, Canaza L, Samalvides F, Seas C.

BMC Public Health. 2013 Dec 28;13:1237. doi: 10.1186/1471-2458-13-1237.

35.

Association of major depressive episode with negative outcomes of tuberculosis treatment.

Ugarte-Gil C, Ruiz P, Zamudio C, Canaza L, Otero L, Kruger H, Seas C.

PLoS One. 2013 Jul 29;8(7):e69514. doi: 10.1371/journal.pone.0069514. Print 2013.

36.

[Knowledge, attitudes, and practices about Carrión's disease in rural Ancash, Peru].

Llerena Luna C, Schweig Groisman M, Ugarte-Gil CA.

Rev Panam Salud Publica. 2013 May;33(5):311-5. Spanish.

PMID:
23764661
37.

Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.

Ugarte-Gil CA, Elkington P, Gilman RH, Coronel J, Tezera LB, Bernabe-Ortiz A, Gotuzzo E, Friedland JS, Moore DA.

PLoS One. 2013 Apr 22;8(4):e61333. doi: 10.1371/journal.pone.0061333. Print 2013.

38.

Private sector contributions and their effect on physician emigration in the developing world.

Loh LC, Ugarte-Gil C, Darko K.

Bull World Health Organ. 2013 Mar 1;91(3):227-33. doi: 10.2471/BLT.12.110791. Epub 2013 Jan 17.

39.

Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for elimination.

Sanchez Clemente N, Ugarte-Gil CA, Solórzano N, Maguiña C, Pachas P, Blazes D, Bailey R, Mabey D, Moore D.

PLoS Negl Trop Dis. 2012;6(10):e1819. doi: 10.1371/journal.pntd.0001819. Epub 2012 Oct 25. Review.

40.

Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru.

Ponce M, Ugarte-Gil C, Zamudio C, Krapp F, Gotuzzo E, Seas C.

Trans R Soc Trop Med Hyg. 2012 Aug;106(8):508-10. doi: 10.1016/j.trstmh.2012.05.008. Epub 2012 Jun 26.

PMID:
22742941
41.

Matrix metalloproteinases in tuberculosis.

Elkington PT, Ugarte-Gil CA, Friedland JS.

Eur Respir J. 2011 Aug;38(2):456-64. doi: 10.1183/09031936.00015411. Epub 2011 Jun 9. Review.

42.

MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, Walker NF, Saraiva L, Pedersen B, Mauri F, Lipman M, Edwards DR, Robertson BD, D'Armiento J, Friedland JS.

J Clin Invest. 2011 May;121(5):1827-33. doi: 10.1172/JCI45666. Epub 2011 Apr 25.

Supplemental Content

Loading ...
Support Center